Ritu Baral

Stock Analyst at TD Cowen

(2.48)
# 2,482
Out of 5,044 analysts
37
Total ratings
46.67%
Success rate
3.17%
Average return

Stocks Rated by Ritu Baral

Avidity Biosciences
Oct 29, 2025
Downgrades: Hold
Price Target: $78$74
Current: $69.93
Upside: +5.82%
Insmed
Oct 2, 2025
Maintains: Buy
Price Target: $154$193
Current: $165.29
Upside: +16.76%
ACADIA Pharmaceuticals
Sep 11, 2025
Maintains: Buy
Price Target: $35$39
Current: $22.62
Upside: +72.41%
Madrigal Pharmaceuticals
Aug 26, 2025
Maintains: Buy
Price Target: $390$554
Current: $429.18
Upside: +29.08%
Akero Therapeutics
Aug 4, 2025
Initiates: Buy
Price Target: $76
Current: $54.00
Upside: +40.74%
Palvella Therapeutics
Feb 5, 2025
Initiates: Buy
Price Target: $44
Current: $73.50
Upside: -40.14%
Spero Therapeutics
Nov 18, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.38
Upside: -
AN2 Therapeutics
Nov 18, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.29
Upside: -
Alnylam Pharmaceuticals
Oct 21, 2024
Maintains: Buy
Price Target: $282$371
Current: $475.91
Upside: -22.04%
Sagimet Biosciences
Aug 8, 2023
Initiates: Outperform
Price Target: n/a
Current: $8.24
Upside: -
Maintains: Outperform
Price Target: $125$175
Current: $24.22
Upside: +622.54%
Downgrades: Market Perform
Price Target: n/a
Current: $124.51
Upside: -
Initiates: Outperform
Price Target: n/a
Current: $0.62
Upside: -
Initiates: Outperform
Price Target: n/a
Current: $14.00
Upside: -
Initiates: Outperform
Price Target: n/a
Current: $5.96
Upside: -
Initiates: Outperform
Price Target: n/a
Current: $29.96
Upside: -
Initiates: Outperform
Price Target: n/a
Current: $8.59
Upside: -
Initiates: Outperform
Price Target: n/a
Current: $1.78
Upside: -
Downgrades: Market Perform
Price Target: n/a
Current: $0.62
Upside: -
Downgrades: Market Perform
Price Target: n/a
Current: $755.00
Upside: -